Nasus Pharma Ltd.
USD3.10
-0.16 (-4.91%)
CEO
Dan Teleman
IPO Date
2025-08-13
Sector
Healthcare
Industry
Biotechnology
Exchange
AMEX
Country
IL
Open
$3.16
Prev. Close
$3.26
Day Low
$3.10
Day High
$3.22
52W Low
$1.98
52W High
$9.99
Market Cap
$0.03B
Volume
0.02M
| 15,000 |
| $2.04 |
| 27 Mar 2026 | Rubin Eyal | officer, other: Chief Financial Officer | Disposed | 40,549 | $7.56 |
| 27 Mar 2026 | Silberman David | director | Disposed | 10,000 | $5.38 |
| 27 Mar 2026 | Teleman Dan Benjamin | director, officer: Chief Executive Officer | Disposed | 0 | $0.00 |
| 27 Mar 2026 | Teleman Dan Benjamin | director, officer: Chief Executive Officer | Disposed | 318,856 | $6.05 |
| 27 Mar 2026 | Shacham Sharon | director | Disposed | 10,000 | $5.38 |
| 27 Mar 2026 | Gilboa Udi | other: Founder & Executive Chairman | Disposed | 0 | $0.00 |
| 27 Mar 2026 | Gilboa Udi | other: Founder & Executive Chairman | Disposed | 0 | $0.00 |
| 27 Mar 2026 | Gilboa Udi | other: Founder & Executive Chairman | Disposed | 17,970 | $6.53 |